5-HT7 receptors

Current Drug Targets: CNS and Neurological Disorders

Volumn 3, Issue 1, 2004, Pages 81-90

  Thomas, David R ^a   Hagan, Jim J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 HT7 receptor; Anxiety; Brain; Circadian rhythms; Cognition; Distribution; Function; Migraine; Schizophrenia; Sleep; Unipolar depression

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 3,N DIMETHYL N [1 METHYL 3 (4 METHYL 1 PIPERIDINYL)PROPYL]BENZENESULFONAMIDE; 4 AMINOBUTYRIC ACID; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BUSPIRONE; CLOZAPINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DR 4004; DR 4365; DR 4446; FLUVOXAMINE; LIGAND; MESSENGER RNA; METITEPINE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROLEPTIC AGENT; PINDOLOL; RISPERIDONE; SB 258741; SB 656104A; SB 691673; SEROTONIN 7 ANTAGONIST; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANXIETY; BINDING AFFINITY; BRAIN FUNCTION; BRAIN NERVE CELL; BRAIN REGION; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CIRCADIAN RHYTHM; COGNITIVE DEFECT; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; EVIDENCE BASED MEDICINE; GASTROINTESTINAL TRACT; HIPPOCAMPUS; HUMAN; LEARNING; MEMORY; MENTAL DISEASE; MIGRAINE; MOLECULAR CLONING; NONHUMAN; PACEMAKER; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; SLEEP DISORDER; SMOOTH MUSCLE RELAXATION; SUPRACHIASMATIC NUCLEUS; THALAMUS; THERMOREGULATION; TISSUE DISTRIBUTION; ANIMAL; BRAIN; CLASSIFICATION; DRUG EFFECT; DRUG SCREENING; GENETIC POLYMORPHISM; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; CLONING, MOLECULAR; DRUG EVALUATION; HUMANS; IMMUNOHISTOCHEMISTRY; LEARNING; MENTAL DISORDERS; NEURONS; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

EID: 3042841937     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007043482633     Document Type: Review

References (127)

1. Plassat, J. L.; Amlaiky, N.; Hen, R. Molecular Pharmacology 1993, 44(2), 229-236.
2. Lovenberg, T. W.; Baron, B. M.; Delecea, L.; Miller, J. D.; Prosser, R. A.; Rea, M. A.; Foye, P. E.; Racke, M.; Slone, A. L.; Siegel, B. W.; Danielson, P. E.; Sutcliffe, J. G.; Erlander, M. G. Neuron 1993, 11(3), 449-458.
3. Meyerhof, W.; Obermuller, F.; Fehr, S.; Richter, D. DNA & Cell Biology 1993, 12(5), 401-409.
4. Ruat, M.; Traiffort, E.; Leurs, R.; Tardivellacombe, J.; Diaz, J.; Arrang, J. M.; Schwartz, J. C. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(18), 8547-8551.
5. Shen, Y.; Monsma, F. J.; Metcalf, M. A.; Jose, P. A.; Hamblin, M. W.; Sibley, D. R. Journal of Biological Chemistry 1993, 268(24), 18200-18204.
6. Tsou, A. P.; Kosaka, A.; Bach, C.; Zuppan, P.; Yee, C.; Tom, L.; Alvarez, R.; Ramsey, S.; Bonhaus, D. W.; Stefanich, E.; Jakeman, L.; Eglen, R. M.; Chan, H. W. Journal of Neurochemistry 1994, 63(2), 456-464.
7. Bhalla, P.; Saxena, P. R.; Sharma, H. S. Molecular & Cellular Biochemistry 2002, 238(1-2), 81-88.
8. Bard, J. A.; Zgombick, J.; Adham, N.; Vaysse, P.; Branchek, T. A.; Weinshank, R. L. Journal of Biological Chemistry 1993, 268(31), 23422-23426.
9. Gelernter, J.; Rao, P. A.; Pauls, D. L.; Hamblin, M. W.; Sibley, D. R.; Kidd, K. K. Genomics 1995, 26(2), 207-209.
10. Erdmann, J.; Nothen, M. M.; Shimronabarbanell, D.; Rietschel, M.; Albus, M.; Borrmann, M.; Maier, W.; Franzek, E.; Korner, J.; Weigelt, B.; Fimmers, R.; Propping, P. Molecular Psychiatry 1996, 1(5), 392-397.
11. Heidmann, D. E. A.; Metcalf, M. A.; Kohen, R.; Hamblin, M. W. Journal of Neurochemistry 1997, 68(4), 1372-1381.
12. Heidmann, D. E. A.; Szot, P.; Kohen, R.; Hamblin, M. W. Neuropharmacology 1998, 37(12), 1621-1632.
13. Krobert, K. A.; Bach, T.; Syversveen, T.; Kvingedal, A. M.; Levy, F. O. Naunyn-Schmiedebergs Archives of Pharmacology 2001, 363(6), 620-632.
14. Krobert, K. A.; Levy, F. O. British Journal of Pharmacology 2002, 135(6), 1563-1571.
15. Hamblin, M. W.; Guthrie, C. R.; Kohen, R.; Heidmann, D. E. Ann. New York Acad. Sci. 1998, 861, 31-37.
16. Eglen, R. M.; Jasper, J. R.; Chang, D. J.; Martin, G. R. Trends in Pharmacological Sciences 1997, 18(4), 104-107.
17. Thomas, D. R.; Gittins, S. A.; Collin, L. L.; Middlemiss, D. N.; Riley, G.; Hagan, J.; Gloger, I.; Ellis, C. E.; Forbes, I. T.; Brown, A. M. British Journal of Pharmacology 1998, 124(6), 1300-1306.
18. Thomas, E. A.; Carson, M. J.; Neal, M. J.; Sutcliffe, J. G. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(25), 14115-14119.
19. Hedlund, P. B.; Carson, M. J.; Sutcliffe, J. G.; Thomas, E. A. Biochemical Pharmacology 1999, 58(11), 1807-1813.
20. Baker, L. P.; Nielsen, M. D.; Impey, S.; Metcalf, M. A.; Poser, S. W.; Chan, G.; Obrietan, K.; Hamblin, M. W.; Storm, D. R. Journal of Biological Chemistry 1998, 273(28), 17469-17476.
21. Schoeffter, P.; Ullmer, C.; Bobirnac, I.; Gabbiani, G.; Lubbert, H. British Journal of Pharmacology 1996, 117(6), 993-994.
22. Gustafson, E. L.; Durkin, M. M.; Bard, J. A.; Zgombick, J.; Branchek, T. A. British Journal of Pharmacology 1996, 117(4), 657-666.
23. To, Z. P.; Bonhaus, D. W.; Eglen, R. M.; Jakeman, L. B. British Journal of Pharmacology 1995, 115(1), 107-116.
24. Neumaier, J. F.; Sexton, T. J.; Yracheta, Y.; Diaz, A. M.; Brownfield, M. Journal of Chemical Neuroanatomy 2001, 21(1), 63-73.
25. Vanhoenacker, P.; Haegeman, G.; Leysen, J. E. Trends in Pharmacological Sciences 2000, 21(2), 70-77.
26. Stowe, R. L.; Barnes, N. M. Neuropharmacology 1998, 37(12), 1611-1619.
27. Thomas, D. R.; Middlemiss, D. N.; Taylor, S. G.; Nelson, P.; Brown, A. M. British Journal of Pharmacology 1999, 128(1), 158-164.
28. Thomas, D. R.; Atkinson, P. J.; Ho, M.; Bromidge, S. M.; Lovell, P. J.; Villani, A. J.; Hagan, J. J.; Middlemiss, D. N.; Price, G. W. British Journal of Pharmacology 2000, 130(2), 409-417.
29. Waeber, C.; Moskowitz, M. A. European Journal of Pharmacology 1995, 283(1-3), 31-46.
30. Duncan, M. J.; Short, J.; Wheeler, D. L. Brain Research 1999, 829(1-2), 39-45.
31. Pickard, G. E.; Smith, B. N.; Belenky, M.; Rea, M. A.; Dudek, F. E.; Sollars, P. J. Journal of Neuroscience 1999, 19(10), 4034-4045.
32. Hemedah, M.; Coupar, I. M.; Mitchelson, F. J. British Journal of Pharmacology 1999, 126(1), 179-188.
33. Sleight, A. J.; Carolo, C.; Petit, N.; Zwingelstein, C.; Bourson, A. Molecular Pharmacology 1995, 47(1), 99-103.
34. Gobbi, M.; Parotti, L.; Mennini, T. Molecular Pharmacology 1996, 49(3), 556-559.
35. Clemett, D. A.; Kendall, D. A.; Cockett, M. I.; Marsden, C. A.; Fone, K. C. F. British Journal of Pharmacology 1999, 127(1), 236-242.
36. Bonaventure, P.; Nepomuceno, D.; Kwok, A.; Chai, W. Y.; Langlois, X.; Hen, R.; Stark, K.; Carruthers, N.; Lovenberg, T. W. Journal of Pharmacology & Experimental Therapeutics 2002, 302(1), 240-248.
37. Thomas, D. R.; Atkinson, P. J.; Hastie, P. G.; Roberts, J. C.; Middlemiss, D. N.; Price, G. W. Neuropharmacology 2002, 42(1), 74-81.
38. Roberts, J. C.; Thomas, D. R.; Hagan, J.; Leslie, R. A. British Journal of Pharmacology 2000, 129, P245.
39. Mshing, D. J.; Cohen, M. L. Journal of Pharmacology & Experimental Therapeutics 1992, 263(1), 123-129.
40. Kikuchi, C.; Nagaso, H.; Hiranuma, T.; Koyama, M. Journal of Medicinal Chemistry 1999, 42(4), 533-535.
41. Forbes, I. T.; Dabbs, S.; Duckworth, D. M.; Jennings, A. J.; King, F. D.; Lovell, P. J.; Brown, A. M.; Collin, L.; Hagan, J. J.; Middlemiss, D. N.; Riley, G. J.; Thomas, D. R.; Upton, N. Journal of Medicinal Chemistry 1998, 41(5), 655-657.
42. Kogan, H. A.; Marsden, C. A.; Fone, K. C. F. European Journal of Pharmacology 2002, 449(1-2), 105-111.
43. Lovell, P. J.; Bromidge, S. M.; Dabbs, S.; Duckworth, D. M.; Forbes, I. T.; Jennings, A. J.; King, F. D.; Middlemiss, D. N.; Rahman, S. K.; Saunders, D. V.; Collin, L. L.; Hagan, J. J.; Riley, G. J.; Thomas, D. R. Journal of Medicinal Chemistry 2000, 43(3), 342-345.
44. Forbes, I. T.; Douglas, S.; Gribble, A. D.; Ife, R. J.; Lightfoot, A. P.; Garner, A. E.; Riley, G. J.; Jeffrey, P.; Stevens, A. J.; Stean, T. O.; Thomas, D. R. Bioorganic & Medicinal Chemistry Letters 2002, 12(22), 3341-3344.
45. Thomas, D.R.; Melotto, S.; Massagrande, M.; Gribble, A. D.; Jeffrey, P.; Stevens, A.J.; Decks, N.J.; Eddershaw, P.J.; Fenwick, S.H.; Riley, G.; Stean, T.; Scott, C.M.; Hill, M.J.; Middlemiss, D.N.; Hagan, J.J.; Price, G.W.; Forbes, I. T. British Journal of Pharmacology 2003, 139 705-714.
46. Forbes, I. T.; Cooper, D. G.; Dodds, E. K.; Douglas, S.; Gribble, A. D.; Ife, R. J.; Lightfoot, A. P.; Meeson, M.; Campbell, L. P.; Riley, G.; Thomas, D. R. Bioorganic & Medicinal Chemistry Letters 2003, 13(6), 1055-1059.
47. Kikuchi, C.; Hiranuma, T.; Koyama, M. Bioorganic & Medicinal Chemistry Letters 2002, 12(18), 2549-2552.
48. Kikuchi, C.; Ando, T.; Watanabe, T.; Nagaso, H.; Okuno, M.; Hiranuma, T.; Koyama, M. Journal of Medicinal Chemistry 2002, 45(11), 2197-2206.
49. Zhang, M. R.; Haradahira, T.; Maeda, J.; Okauchi, T.; Kida, T.; Obayashi, S.; Suzuki, K.; Suhara, T. Journal of Labelled Compounds & Radiopharmaceuticals 2002, 45(10), 857-866.
50. Kikuchi, C.; Suzuki, H.; Hiranuma, T.; Koyama, M. Bioorganic & Medicinal Chemistry Letters 2003, 13(1), 61-64.
51. Isaac, M. B.; Xin, T.; O'Brien, A.; St Martin, D.; Naismith, A.; MacLean, N.; Wilson, J.; Demchyshyn, L.; Tehim, A.; Slassi, A. Bioorganic & Medicinal Chemistry Letters 2002, 12(17), 2451-2454.
52. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R.; Humphrey, P. P. A. Pharmacological Reviews 1994, 46(2), 157-203.
53. Carter, D.; Champney, M.; Hwang, B.; Eglen, R. M. European Journal of Pharmacology 1995, 280(3), 243-250.
54. Prins, N. H.; Briejer, M. R.; Van Bergen, P. J. E.; Akkermans, L. M. A.; Schuurkes, J. A. J. British Journal of Pharmacology 1999, 128(4), 849-852.
55. Terron, J. A.; Falcon-Neri, A. British Journal of Pharmacology 1999, 127(3), 609-616.
56. Contesse, V.; Lenglet, S.; Grumolato, L.; Anouar, Y.; Lihrmann, I.; Lefebvre, H.; Delarue, C.; Vaudry, H. Molecular Pharmacology 1999, 56(3), 552-561.
57. Hagan, J. J.; Price, G. W.; Jeffrey, P.; Deeks, N. J.; Stean, T.; Piper, D.; Smith, M. I.; Upton, N.; Medhurst, A. D.; Middlemiss, D. N.; Riley, G. J.; Lovell, P. J.; Bromidge, S. M.; Thomas, D. R. British Journal of Pharmacology 2000, 130(3), 539-548.
58. Thomas, D. R.; Brown, A. M.; Taylor, S. G.; Middlemiss, D. N. British Journal of Pharmacology 1999, 128, 158-164.
59. Markstein, R.; Matsumoto, M.; Kohler, C.; Togashi, H.; Yoshioka, M.; Hoyer, D. Naunyn-Schmiedebergs Archives of Pharmacology 1999, 359(6), 454-459.
60. Bacon, W. L.; Beck, S. G. Journal of Pharmacology & Experimental Therapeutics 2000, 294(2), 672-679.
61. Gill, C. H.; Soffin, E. M.; Hagan, J. J.; Davies, C. H. Neuropharmacology 2002, 42(1), 82-92.
62. Choudhury, H. I.; Peterson, D.; Rosahl, T.; Mcallister, G.; Seabrook, G. R.; Maubach, K. British Journal of Pharmacology 2003, In press
63. Matsumoto, M.; Kojima, T.; Togashi, H.; Mori, K.; Ohashi, S.; Ueno, K.; Yoshioka, M. Naunyn-Schmiedebergs Archives of Pharmacology 2002, 366(6), 570-577.
64. Goaillard, J. M.; Vincent, P. Journal of Physiology-London 2002, 541(2), 453-465.
65. Bickmeyer, U.; Heine, M.; Manzke, T.; Richter, D. W. European Journal of Neuroscience 2002, 16(2), 209-218.
66. Chapin, E. M.; Andrade, R. Journal of Pharmacology & Experimental Therapeutics 2001, 297(1), 395-402.
67. Chapin, E. M.; Andrade, R. wJournal of Pharmacology & Experimental Therapeutics 2001, 297(1), 403-409.
68. Rusak, B.; Zucker, I. Physiological Reviews 1979, 59(3), 449-526.
69. Rea, M. A.; Pickard, G. E. Biological Rhythm Research 2000, 31(3), 284-314.
70. Ying, S. W.; Rusak, B. Brain Research 1997, 755(2), 246-254.
71. Ehlen, J. C.; Grossman, G. H.; Glass, J. D. Journal of Neuroscience 2001, 21(14), 5351-5357.
72. Antle, M. C.; Ogilvie, M. D.; Pickard, G. E.; Mistlberger, R. E. Journal of Biological Rhythms 2003, 18(2), 145-158.
73. Stowe, R. L.; Barnes, N. M. British Journal of Pharmacology 1998, 125, 55P.
74. Kawahara, F.; Saito, H.; Katsuki, H. Journal of Physiology 1994, 478(1), 67-73.
75. Prosser, R. A. Biological Rhythm Research 2000, 31, 315-339.
76. Jovanovska, A.; Prosser, R. A. Journal of Biological Rhythms 2002, 17(2), 137-146.
77. Oliver, K. R.; Kinsey, A. M.; Wainwright, A.; Sirinathsinghji, D. J. S. Brain Research 2000, 867(1-2), 131-142.
78. Gannon, R. L. Journal of Biological Rhythms 2001, 16(1), 19-24.
79. Roberts, C.; Thomas, D. R.; Kew, J. N. C. British Journal of Pharmacology 2003, 137, 132P.
80. Glass, J. D.; Grossman, G. H.; Farnbauch, L.; DiNardo, L. Journal of Neuroscience 2003, 23(20), 7451-7460.
81. Duncan, M. J.; Temel, S.; Jennes, L. Soc.for Neurosci.Abstr. 2001
82. Inoue, T.; Itoh, S.; Wakisaka, S.; Ogawa, S.; Saito, M.; Morimoto, T. Brain Research 2002, 954(2), 202-211.
83. Meuser, T.; Pietruck, C.; Gabriel, A.; Xie, G. X.; Lim, K. J.; Palmer, P. P. Life Sciences 2002, 71(19), 2279-2289.
84. Guscott M.R.; Egan, E.; Cook, G.P.; Stanton, J.A.; Beer, M.S.; Rosahl, T.W.; Hartmann, S.; Kulagowski, J.; McAllister, G.; Forte, K.C.F.; Hutson, P.H. Neuropharmacology, 2003, 44, 1031-1037
85. Hedlund, P. B.; Danielson, P. E.; Thomas, E. A.; Slanina, K.; Carson, M. J.; Sutcliffe, J. G. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(3), 1375-1380.
86. Dijk, D. J.; Czeisler, C. A. Journal of Neuroscience 1995, 15(5 Part 1), 3526-3538.
87. Pace-Schott, E. F.; Hobson, J. A. Nature Reviews Neuroscience 2002, 3(8), 591-605.
88. Roberts, C.; Langmead, C. J.; Soffin, E. M.; Davies, C. H.; Lacroix, L.; Heidbreder, C. A. in Monitoring Molecules in Neuroscience, O'Connor, W. T.; Lowry, J. P.; O'Connor, J. J.; O'neill, R. D., editors; 2001; pp. 348-350.
89. Xi, M. C.; Morales, F. R.; Chase, M. H. Archives Italiennes de Biologie 2001, 139(1-2), 125-145.
90. Boivin, D. B.; Czeisler, C. A.; Dijk, D. J.; Duffy, J. F.; Folkard, S.; Minors, D. S.; Totterdell, P.; Waterhouse, J. M. Archives of General Psychiatry 1997, 54(2), 145-152.
91. Jones, S. H. Clinical Psychology Review 2001, 21(8), 1193-1209.
92. Katz, G.; Durst, R.; Zislin, Y.; Barel, Y.; Knobler, H. Y. Medical Hypotheses 2001, 56(1), 20-23.
93. Brunello, N.; Armitage, R.; Feinberg, I.; Holsboer-Trachsler, E.; Leger, D.; Linkowski, P.; Mendelson, W. B.; Racagni, G.; Saletu, B.; Sharpley, A. L.; Turek, F.; Van Cauter, E.; Mendlewicz, J. Neuropsychobiology 2000, 42(3), 107-119.
94. Staner, L.; Luthringer, R.; Macher, J. P. CNS Drugs 1999, 11(1), 49-60.
95. Ott, G. E.; Rao, U.; Nuccio, I.; Lin, K. M.; Poland, R. E. Psychopharmacology 2002, 165(1), 29-36.
96. Johnson, M. S.; Lutz, E. A.; Firbank, S.; Holland, P. J.; Mitchell, R. Cellular Signalling 2003, 15(8), 803-811.
97. Mullins, U. L.; Gianutsos G.; Eison, A. S Neuropsychopharmacology 1999, 21, 352-367.
98. Atkinson, P.J.; Duxon, M.S.; Price, G.W.; Hastie, P.G.; Thomas, D.R. British Journal of Pharmacology 2001, 134, 40.
99. Guscott M.R. Society for Neuroscience Satellite Meeting; Serotonin: From the Molecule to the Clinic. 2000 P81.
100. Yau, J. L. W.; Noble, J.; Seckl, J. R. Neuroscience Letters 2001, 309(3), 141-144.
101. Yau, J. L. W.; Noble, J.; Widdowson, J.; Seckl, J. R. Molecular Brain Research 1997, 45(1), 182-186.
102. Le Corre, S.; Sharp, T.; Young, A. H.; Harrison, P. J. Psychopharmacology 1997, 130(4), 368-374.
103. Laplante, P.; Diorio, J.; Meaney, M. J. Brain Research: Developmental Brain Research 2002, 139(2), 199-203.
104. Sapolsky, R. M. Archives of General Psychiatry 2000, 57(10), 925-935.
105. McEwen, B. S. Biological Psychiatry 2000, 48(8), 721-731.
106. Errico, H.; Crozier, R. A.; Plummer, M. R.; Cowen, D. S. Neuroscience 2001, 102(2), 361-367.
107. D'Sa, C.; Duman, R. S. Bipolar Disorders 2002, 4(3), 183-194.
108. Meneses, A.; Terron, J. A. Behavioural Brain Research 2001, 121(1-2), 21-28.
109. Meneses, A. Neuroscience & Biobehavioral Reviews 2002, 26(3), 309-319.
110. Menard, J.; Treit, D. Neuroscience & Biobehavioral Reviews 1999, 23(4), 591-613.
111. Sharp, T.; Mcquade, R.; Bramwell, S.; Hjorth, S. Naunyn-Schmiedebergs Archives of Pharmacology 1993, 348(4), 339-346.
112. Harrison, P. J. Brain 1999, 122(Part 4), 593-624.
113. Lewis, D. A.; Pierri, J. N.; Volk, D. W.; Melchitzky, D. S.; Woo, T. U. W. Biological Psychiatry 1999, 46(5), 616-626.
114. Vysokanov, A.; Flores-Hernandez, J.; Surmeier, D. J. Neuroscience Letters 1998, 258(3), 179-182.
115. East, S. Z.; Burnet, P. W. J.; Kerwin, R. W.; Harrison, P. J. Schizophrenia Research 2002, 57(1), 15-26.
116. Roth, B. L.; Craigo, S. C.; Choudhary, M. S.; Uluer, A.; Monsma, F. J.; Shen, Y.; Meltzer, H. Y.; Sibley, D. R. Journal of Pharmacology & Experimental Therapeutics 1994, 268(3), 1403-1410.
117. Zhukovskaya, N. L.; Neumaier, J. F. Neuroscience Letters 2000, 288(3), 236-240.
118. Pouzet, B.; Didriksen, M.; Arnt, J. Pharmacology, Biochemistry & Behavior 2002, 71(4), 655-665.
119. Cardenas, C. G.; Del Mar, L. P.; Vysokanov, A. V.; Arnold, P. B.; Cardenas, L. M.; Surmeier, D. J.; Scroggs, R. S. Journal of Physiology-London 1999, 518(2), 507-523.
120. Price, D. D. Science 2000, 288(5472), 1769-1772.
121. Terron, J. A. European Journal of Pharmacology 2002, 439(1-3), 1-11.
122. Ullmer, C.; Schmuck, K.; Kalkman, H. O.; Lubbert, H. FEBS Letters 1995, 370(3), 215-221.
123. Schmuck, K.; Ullmer, C.; Kalkman, H. O.; Probst, A.; Lubbert, H. European Journal of Neuroscience 1996, 8(5), 959-967.
124. Conley, R. K.; Williams, T. J.; Ford, A. P. D. W.; Ramage, A. G. British Journal of Pharmacology 2001, 133(1), 61-72.
125. Barnes, N. M.; Sharp, T. Neuropharmacology 1999, 38(8), 1083-1152.
126. Read, K. E.; Sanger, G. J.; Ramage, A. G. British Journal of Pharmacology. 2003, 140, 53-60.
127. Bourson, A.; Kapps, V.; Zwingelstein, C.; Rudler, A.; Boess, F. G.; Sleight, A. J. Naunyn-Schmiedebergs Archives of Pharmacology 1997, 356(6), 820-826.